Michael T. McCaul sold Neurocrine Biosciences Inc (NASDAQ: NBIX)
Michael T. McCaul (R-TX), a U.S. Representative, has disclosed 26 trades in Neurocrine Biosciences Inc (NBIX) since 2019, 12 purchases and 14 sales, worth an estimated $922K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Michael T. McCaul sold $1,001 - $15,000 of Neurocrine Biosciences Inc (NASDAQ: NBIX) on December 14, 2021. Since that trade, NBIX is up +118.58% against the S&P 500 up +67.47%, an outperformance of +51.11%.
Across these filings, Michael T. McCaul has been a net seller of NBIX (a buy-to-sell ratio of 0.86). The most recent disclosed NBIX transaction shown was dated August 14, 2023. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Michael T. McCaul's NBIX trades vs the price
NBIX is up +118.58% since Michael T. McCaul sold on December 14, 2021, versus +67.47% for the S&P 500.
Performance since this trade
All Michael T. McCaul NBIX trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Michael T. McCaul & NBIX trading FAQ
Is it legal for Michael T. McCaul to trade Neurocrine Biosciences Inc (NBIX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Neurocrine Biosciences Inc (NBIX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Michael T. McCaul sell NBIX?
Michael T. McCaul disclosed a sale of $1,001 - $15,000 of Neurocrine Biosciences Inc (NBIX) on December 14, 2021, according to public STOCK Act filings.
How has NBIX performed since Michael T. McCaul's trade?
Since Michael T. McCaul sold NBIX on December 14, 2021, the stock is up +118.58%, versus +67.47% for the S&P 500 over the same period, an outperformance of +51.11%.
How many times has Michael T. McCaul traded NBIX?
Michael T. McCaul has disclosed 26 NBIX trades since 2019 (12 purchases and 14 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NBIX trades?
Quantellect tracks every disclosed congressional trade in Neurocrine Biosciences Inc (NBIX) on the Neurocrine Biosciences Inc congressional trading page, which aggregates filings across all members of Congress.
Michael T. McCaul's NBIX tradesAll congressional filings for Neurocrine Biosciences IncMichael T. McCaul's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.